Vergis, J. and McCullumsmith, R.E. 2025. Pathway enrichment and FDA-approved drug repurposing analysis for the treatment of CTNNB1 Syndrome modeled in an SH-SY5Y cell line. Translation: The University of Toledo Journal of Medical Sciences. 14, S1 (Oct. 2025). DOI:https://doi.org/10.46570/utjms-2025-1507.